Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinics in Podiatric Medicine and Surgery|June 18, 2022
Update on Fibrocartilaginous Disease Clinical ExaminationMichelle L Butterworth, Alan J Block
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|December 26, 2002
Evaluation of the anterior and middle talocalcaneal articular facets and the Evans osteotomyChristopher F Hyer, Thomas Lee, Alan J Block, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|July 14, 2005
Treatment of recalcitrant intermetatarsal neuroma with 4% sclerosing alcohol injection: a pilot studyChristopher F Hyer, Lynette R Mehl, Alan J Block, et al.
Circulation|September 17, 2003
Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationshipGary F Mitchell, Yves Lacourcière, Jean-Pascal Ouellet, et al.
Circulation|June 26, 2002
Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research studyGary F Mitchell, Joseph L Izzo, Yves Lacourcière, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.
Lancet (London, England)|July 18, 2008
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Pageof 1